Serveur d'exploration sur le peuplier

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient.

Identifieur interne : 003D64 ( Main/Exploration ); précédent : 003D63; suivant : 003D65

Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient.

Auteurs : Aeron C. Hurt [Australie] ; Pina Iannello ; Kim Jachno ; Naomi Komadina ; Alan W. Hampson ; Ian G. Barr ; Jennifer L. Mckimm-Breschkin

Source :

RBID : pubmed:16641465

Descripteurs français

English descriptors

Abstract

An influenza B virus from an infant with no history of treatment or contact with neuraminidase inhibitors demonstrated a significant reduction in sensitivity to these drugs. Here, we describe the analysis of a mixed viral population that contained a novel D197E amino acid substitution that was responsible for this reduction.

DOI: 10.1128/AAC.50.5.1872-1874.2006
PubMed: 16641465
PubMed Central: PMC1472236


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient.</title>
<author>
<name sortKey="Hurt, Aeron C" sort="Hurt, Aeron C" uniqKey="Hurt A" first="Aeron C" last="Hurt">Aeron C. Hurt</name>
<affiliation wicri:level="1">
<nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, 45 Poplar Rd., Parkville, Victoria 3052, Australia. Aeron.Hurt@influenzacentre.org</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>WHO Collaborating Centre for Reference and Research on Influenza, 45 Poplar Rd., Parkville, Victoria 3052</wicri:regionArea>
<wicri:noRegion>Victoria 3052</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Iannello, Pina" sort="Iannello, Pina" uniqKey="Iannello P" first="Pina" last="Iannello">Pina Iannello</name>
</author>
<author>
<name sortKey="Jachno, Kim" sort="Jachno, Kim" uniqKey="Jachno K" first="Kim" last="Jachno">Kim Jachno</name>
</author>
<author>
<name sortKey="Komadina, Naomi" sort="Komadina, Naomi" uniqKey="Komadina N" first="Naomi" last="Komadina">Naomi Komadina</name>
</author>
<author>
<name sortKey="Hampson, Alan W" sort="Hampson, Alan W" uniqKey="Hampson A" first="Alan W" last="Hampson">Alan W. Hampson</name>
</author>
<author>
<name sortKey="Barr, Ian G" sort="Barr, Ian G" uniqKey="Barr I" first="Ian G" last="Barr">Ian G. Barr</name>
</author>
<author>
<name sortKey="Mckimm Breschkin, Jennifer L" sort="Mckimm Breschkin, Jennifer L" uniqKey="Mckimm Breschkin J" first="Jennifer L" last="Mckimm-Breschkin">Jennifer L. Mckimm-Breschkin</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16641465</idno>
<idno type="pmid">16641465</idno>
<idno type="doi">10.1128/AAC.50.5.1872-1874.2006</idno>
<idno type="pmc">PMC1472236</idno>
<idno type="wicri:Area/Main/Corpus">003E15</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">003E15</idno>
<idno type="wicri:Area/Main/Curation">003E15</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">003E15</idno>
<idno type="wicri:Area/Main/Exploration">003E15</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient.</title>
<author>
<name sortKey="Hurt, Aeron C" sort="Hurt, Aeron C" uniqKey="Hurt A" first="Aeron C" last="Hurt">Aeron C. Hurt</name>
<affiliation wicri:level="1">
<nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, 45 Poplar Rd., Parkville, Victoria 3052, Australia. Aeron.Hurt@influenzacentre.org</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>WHO Collaborating Centre for Reference and Research on Influenza, 45 Poplar Rd., Parkville, Victoria 3052</wicri:regionArea>
<wicri:noRegion>Victoria 3052</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Iannello, Pina" sort="Iannello, Pina" uniqKey="Iannello P" first="Pina" last="Iannello">Pina Iannello</name>
</author>
<author>
<name sortKey="Jachno, Kim" sort="Jachno, Kim" uniqKey="Jachno K" first="Kim" last="Jachno">Kim Jachno</name>
</author>
<author>
<name sortKey="Komadina, Naomi" sort="Komadina, Naomi" uniqKey="Komadina N" first="Naomi" last="Komadina">Naomi Komadina</name>
</author>
<author>
<name sortKey="Hampson, Alan W" sort="Hampson, Alan W" uniqKey="Hampson A" first="Alan W" last="Hampson">Alan W. Hampson</name>
</author>
<author>
<name sortKey="Barr, Ian G" sort="Barr, Ian G" uniqKey="Barr I" first="Ian G" last="Barr">Ian G. Barr</name>
</author>
<author>
<name sortKey="Mckimm Breschkin, Jennifer L" sort="Mckimm Breschkin, Jennifer L" uniqKey="Mckimm Breschkin J" first="Jennifer L" last="Mckimm-Breschkin">Jennifer L. Mckimm-Breschkin</name>
</author>
</analytic>
<series>
<title level="j">Antimicrobial agents and chemotherapy</title>
<idno type="ISSN">0066-4804</idno>
<imprint>
<date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acetamides (pharmacology)</term>
<term>Amino Acid Substitution (MeSH)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Baculoviridae (genetics)</term>
<term>Base Sequence (MeSH)</term>
<term>Cyclopentanes (pharmacology)</term>
<term>Drug Resistance, Viral (genetics)</term>
<term>Enzyme Inhibitors (pharmacology)</term>
<term>Enzyme Inhibitors (therapeutic use)</term>
<term>Female (MeSH)</term>
<term>Guanidines (pharmacology)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Influenza B virus (drug effects)</term>
<term>Influenza B virus (isolation & purification)</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (virology)</term>
<term>Inhibitory Concentration 50 (MeSH)</term>
<term>Microbial Sensitivity Tests (MeSH)</term>
<term>Molecular Sequence Data (MeSH)</term>
<term>Neuraminidase (antagonists & inhibitors)</term>
<term>Neuraminidase (genetics)</term>
<term>Oseltamivir (MeSH)</term>
<term>Pyrans (pharmacology)</term>
<term>Recombinant Proteins (antagonists & inhibitors)</term>
<term>Sialic Acids (pharmacology)</term>
<term>Zanamivir (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acides sialiques (pharmacologie)</term>
<term>Acétamides (pharmacologie)</term>
<term>Antienzymes (pharmacologie)</term>
<term>Antienzymes (usage thérapeutique)</term>
<term>Antiviraux (pharmacologie)</term>
<term>Baculoviridae (génétique)</term>
<term>Concentration inhibitrice 50 (MeSH)</term>
<term>Cyclopentanes (pharmacologie)</term>
<term>Données de séquences moléculaires (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (traitement médicamenteux)</term>
<term>Grippe humaine (virologie)</term>
<term>Guanidines (pharmacologie)</term>
<term>Humains (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>Oséltamivir (MeSH)</term>
<term>Protéines recombinantes (antagonistes et inhibiteurs)</term>
<term>Pyrannes (pharmacologie)</term>
<term>Résistance virale aux médicaments (génétique)</term>
<term>Sialidase (antagonistes et inhibiteurs)</term>
<term>Sialidase (génétique)</term>
<term>Substitution d'acide aminé (MeSH)</term>
<term>Séquence nucléotidique (MeSH)</term>
<term>Tests de sensibilité microbienne (MeSH)</term>
<term>Virus influenza B (effets des médicaments et des substances chimiques)</term>
<term>Virus influenza B (isolement et purification)</term>
<term>Zanamivir (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Neuraminidase</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Acetamides</term>
<term>Antiviral Agents</term>
<term>Cyclopentanes</term>
<term>Enzyme Inhibitors</term>
<term>Guanidines</term>
<term>Pyrans</term>
<term>Sialic Acids</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Protéines recombinantes</term>
<term>Sialidase</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Influenza B virus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Virus influenza B</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Baculoviridae</term>
<term>Drug Resistance, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Baculoviridae</term>
<term>Résistance virale aux médicaments</term>
<term>Sialidase</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Influenza B virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Virus influenza B</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Acides sialiques</term>
<term>Acétamides</term>
<term>Antienzymes</term>
<term>Antiviraux</term>
<term>Cyclopentanes</term>
<term>Guanidines</term>
<term>Pyrannes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Enzyme Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antienzymes</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Substitution</term>
<term>Base Sequence</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Inhibitory Concentration 50</term>
<term>Microbial Sensitivity Tests</term>
<term>Molecular Sequence Data</term>
<term>Oseltamivir</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Concentration inhibitrice 50</term>
<term>Données de séquences moléculaires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Nourrisson</term>
<term>Oséltamivir</term>
<term>Substitution d'acide aminé</term>
<term>Séquence nucléotidique</term>
<term>Tests de sensibilité microbienne</term>
<term>Zanamivir</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">An influenza B virus from an infant with no history of treatment or contact with neuraminidase inhibitors demonstrated a significant reduction in sensitivity to these drugs. Here, we describe the analysis of a mixed viral population that contained a novel D197E amino acid substitution that was responsible for this reduction.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">16641465</PMID>
<DateCompleted>
<Year>2006</Year>
<Month>06</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0066-4804</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>50</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2006</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Antimicrobial agents and chemotherapy</Title>
<ISOAbbreviation>Antimicrob Agents Chemother</ISOAbbreviation>
</Journal>
<ArticleTitle>Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient.</ArticleTitle>
<Pagination>
<MedlinePgn>1872-4</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>An influenza B virus from an infant with no history of treatment or contact with neuraminidase inhibitors demonstrated a significant reduction in sensitivity to these drugs. Here, we describe the analysis of a mixed viral population that contained a novel D197E amino acid substitution that was responsible for this reduction.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hurt</LastName>
<ForeName>Aeron C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo>
<Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, 45 Poplar Rd., Parkville, Victoria 3052, Australia. Aeron.Hurt@influenzacentre.org</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Iannello</LastName>
<ForeName>Pina</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jachno</LastName>
<ForeName>Kim</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Komadina</LastName>
<ForeName>Naomi</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hampson</LastName>
<ForeName>Alan W</ForeName>
<Initials>AW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Barr</LastName>
<ForeName>Ian G</ForeName>
<Initials>IG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McKimm-Breschkin</LastName>
<ForeName>Jennifer L</ForeName>
<Initials>JL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>GENBANK</DataBankName>
<AccessionNumberList>
<AccessionNumber>DQ174087</AccessionNumber>
<AccessionNumber>DQ174088</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Antimicrob Agents Chemother</MedlineTA>
<NlmUniqueID>0315061</NlmUniqueID>
<ISSNLinking>0066-4804</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000081">Acetamides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003517">Cyclopentanes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006146">Guanidines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011714">Pyrans</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012794">Sialic Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.2.1.18</RegistryNumber>
<NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>L6O3XI777I</RegistryNumber>
<NameOfSubstance UI="D053243">Zanamivir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>QW7Y7ZR15U</RegistryNumber>
<NameOfSubstance UI="C414210">peramivir</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000081" MajorTopicYN="N">Acetamides</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016367" MajorTopicYN="N">Baculoviridae</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003517" MajorTopicYN="N">Cyclopentanes</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006146" MajorTopicYN="N">Guanidines</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009981" MajorTopicYN="N">Influenza B virus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011714" MajorTopicYN="N">Pyrans</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012794" MajorTopicYN="N">Sialic Acids</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053243" MajorTopicYN="N">Zanamivir</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2006</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2006</Year>
<Month>6</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2006</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">16641465</ArticleId>
<ArticleId IdType="pii">50/5/1872</ArticleId>
<ArticleId IdType="doi">10.1128/AAC.50.5.1872-1874.2006</ArticleId>
<ArticleId IdType="pmc">PMC1472236</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Pediatr Infect Dis J. 2001 Feb;20(2):127-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11224828</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1895-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11779389</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2002 May;54(2):79-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12062393</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2002 Aug;55(2):307-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12103431</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2004 Apr;62(1):37-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15026200</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2004 Jul;103(1-2):199-203</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15163510</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2001 Feb 15;183(4):523-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11170976</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2004 Aug 28-Sep 3;364(9436):759-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15337401</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 1992 Jan;11(1):49-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1740114</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proteins. 1992 Nov;14(3):327-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1438172</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Protein Sci. 1994 Oct;3(10):1687-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7849585</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 1998 Nov;178(5):1257-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9780244</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2000 Jul;47(1):1-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10930642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2004 Jul;103(1-2):205-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15163511</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Barr, Ian G" sort="Barr, Ian G" uniqKey="Barr I" first="Ian G" last="Barr">Ian G. Barr</name>
<name sortKey="Hampson, Alan W" sort="Hampson, Alan W" uniqKey="Hampson A" first="Alan W" last="Hampson">Alan W. Hampson</name>
<name sortKey="Iannello, Pina" sort="Iannello, Pina" uniqKey="Iannello P" first="Pina" last="Iannello">Pina Iannello</name>
<name sortKey="Jachno, Kim" sort="Jachno, Kim" uniqKey="Jachno K" first="Kim" last="Jachno">Kim Jachno</name>
<name sortKey="Komadina, Naomi" sort="Komadina, Naomi" uniqKey="Komadina N" first="Naomi" last="Komadina">Naomi Komadina</name>
<name sortKey="Mckimm Breschkin, Jennifer L" sort="Mckimm Breschkin, Jennifer L" uniqKey="Mckimm Breschkin J" first="Jennifer L" last="Mckimm-Breschkin">Jennifer L. Mckimm-Breschkin</name>
</noCountry>
<country name="Australie">
<noRegion>
<name sortKey="Hurt, Aeron C" sort="Hurt, Aeron C" uniqKey="Hurt A" first="Aeron C" last="Hurt">Aeron C. Hurt</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D64 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003D64 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    PoplarV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:16641465
   |texte=   Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:16641465" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a PoplarV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 12:07:19 2020. Site generation: Wed Nov 18 12:16:31 2020